Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2009 1
2013 1
2014 5
2015 5
2016 5
2017 5
2018 2
2019 2
2020 3
2021 3
2022 4
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Systemic treatment of brain metastases in non-small cell lung cancer.
Page S, Milner-Watts C, Perna M, Janzic U, Vidal N, Kaudeer N, Ahmed M, McDonald F, Locke I, Minchom A, Bhosle J, Welsh L, O'Brien M. Page S, et al. Among authors: bhosle j. Eur J Cancer. 2020 Jun;132:187-198. doi: 10.1016/j.ejca.2020.03.006. Epub 2020 May 4. Eur J Cancer. 2020. PMID: 32380429 Review.
Rationale and Design of the Phase III KEYLYNK-012 Study of Pembrolizumab and Concurrent Chemoradiotherapy Followed by Pembrolizumab With or Without Olaparib for Stage III Non-Small-Cell Lung Cancer.
Jabbour SK, Cho BC, Bria E, Kato T, Bhosle J, Gainor JF, Reguart N, Wang L, Morgensztern D, Shentu Y, Kim SJ, Souza F, Reck M. Jabbour SK, et al. Among authors: bhosle j. Clin Lung Cancer. 2022 Sep;23(6):e342-e346. doi: 10.1016/j.cllc.2022.04.003. Epub 2022 Apr 29. Clin Lung Cancer. 2022. PMID: 35618629 Free PMC article. Clinical Trial.
HER3 expression and MEK activation in non-small-cell lung carcinoma.
Manickavasagar T, Yuan W, Carreira S, Gurel B, Miranda S, Ferreira A, Crespo M, Riisnaes R, Baker C, O'Brien M, Bhosle J, Popat S, Banerji U, Lopez J, de Bono J, Minchom A. Manickavasagar T, et al. Among authors: bhosle j. Lung Cancer Manag. 2021 Apr 9;10(2):LMT48. doi: 10.2217/lmt-2020-0031. Lung Cancer Manag. 2021. PMID: 34084213 Free PMC article.
Olaparib as maintenance treatment in patients with chemosensitive small cell lung cancer (STOMP): A randomised, double-blind, placebo-controlled phase II trial.
Woll P, Gaunt P, Danson S, Steele N, Ahmed S, Mulatero C, Shah R, Bhosle J, Hodgkinson E, Watkins B, Billingham L. Woll P, et al. Among authors: bhosle j. Lung Cancer. 2022 Sep;171:26-33. doi: 10.1016/j.lungcan.2022.07.007. Epub 2022 Jul 15. Lung Cancer. 2022. PMID: 35872530 Free article. Clinical Trial.
Up-front cell-free DNA next generation sequencing improves target identification in UK first line advanced non-small cell lung cancer (NSCLC) patients.
Cui W, Milner-Watts C, O'Sullivan H, Lyons H, Minchom A, Bhosle J, Davidson M, Yousaf N, Scott S, Faull I, Kushnir M, Nagy R, O'Brien M, Popat S. Cui W, et al. Among authors: bhosle j. Eur J Cancer. 2022 Aug;171:44-54. doi: 10.1016/j.ejca.2022.05.012. Epub 2022 Jun 12. Eur J Cancer. 2022. PMID: 35704974 Free article.
35 results